CYP2B6 and metabolic dysfunction-associated steatotic liver disease: Differences in hepatic lipid accumulation between Cyp2b-null and hCYP2B6-Tg mice were examined to determine if the presence of hCYP2B6 provided protection from NAFLD as do murine Cyp2b members in male mice [5, 10].